VXRT - Coronavirus Vaccine Race: Moderna or Vaxart?
Let's talk about two companies developing COVID-19 vaccines that are much different from the ones we're generally used to. These two aren't going the traditional route of injecting a weakened version of the pathogen into the body. They have new ways of addressing the problem.
You've probably heard of Moderna (NASDAQ: MRNA) by now. Moderna has taken center stage over the past few months as it became the first company to bring a COVID-19 vaccine into human trials. The biotech company is developing a vaccine that harnesses the power of messenger RNA to instruct the body to make proteins to defend itself.
Image source: Getty Images.